Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
Clinical trial NCT03980769 · RECRUITING
Trial details
- NCT number
- NCT03980769
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2028-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.